Indivina

Medroxyprogesterone acetate, the active ingredient in Indivina, is a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. Together with estradiol valerate it prevents pregnancy and helps regulate menstrual cycles in women of reproductive age.

GNH USA supplies Indivina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indivina is a combined estrogen‑progestogen oral contraceptive used in the reproductive health field. It provides reliable contraception and menstrual management.

- Prevention of pregnancy: offers a highly effective, reversible method of birth control. - Regulation of menstrual cycles: promotes more predictable bleeding patterns and reduces dysmenorrhea. - Management of hormone‑related menstrual disorders: helps control heavy or irregular bleeding associated with hormonal imbalance.

Indivina may cause a range of adverse reactions. Most are mild and transient, but rare serious events can occur.

Common Side Effects: - Nausea or gastrointestinal discomfort - Breast tenderness or enlargement - Headache or migraine - Weight gain or fluid retention - Mood changes or irritability - Spotting or breakthrough bleeding

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension - Liver dysfunction or cholestasis - Gallbladder disease (biliary colic, cholelithiasis) - Anaphylaxis or severe allergic reaction

Before prescribing Indivina, clinicians should consider several safety factors. - Cardiovascular risk assessment: evaluate history of thrombosis, hypertension, or smoking. - Liver function review: avoid use in active liver disease or severe impairment. - Cancer screening: contraindicated in estrogen‑sensitive malignancies. - Smoking status: advise cessation, especially in women over 35. - Concomitant medication check: assess for drugs that may alter hormonal efficacy. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Indivina can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may reduce anticoagulant effect. - Enzyme‑inducing antiepileptics (phenytoin, carbamazepine): can lower hormone levels. - Rifampin: increases metabolism of both hormones, decreasing contraceptive reliability.

Moderate Interactions (Monitor Closely): - Certain antibiotics (tetracycline, fluoroquinolones): may slightly reduce contraceptive efficacy. - Antifungal agents (ketoconazole, itraconazole): can increase hormone concentrations, raising side‑effect risk.